Skip to main content
profile image
Selected Works of Achal Achrol, MD
Article
ATIM-30. COMBATING RECURRENT GLIOBLASTOMA WITH MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, THROUGH MRI-GUIDED CONVECTIVE DELIVERY
Neuro-oncology (2019)
  • John Sampson, Duke University
  • Achal Singh Achrol, Pacific Neurosciences Institute and John Wayne Cancer Institute, Santa Monica, CA, USA
  • Manish Aghi, University of California, San Francisco
  • Krystof Bankiewicz, University of California, San Francisco
  • Steven Brem, University of Pennsylvania
  • Andrew Brenner, University of Texas Health Science Center at San Antonio
  • Nicholas Butowski, University of California, San Francisco
  • Chandtip Chandhasin, Medicenna Biopharma, Houston, TX, USA
  • Sajeel Chowdhary, Boca Raton Regional Hospital
  • Melissa Coello, Medicenna Biopharma, Houston, TX, USA
  • John R Floyd, University of Texas Health Science Center at San Antonio
  • Santosh Kesari, John Wayne Cancer Institute, Santa Monica, CA, USA
  • Fahar Merchant, Medicenna Biopharma, Houston, TX, USA
  • Nina Merchant, Medicenna Biopharma, Houston, TX, USA
  • Dina Randazzo, Duke University
  • Michael Vogelbaum, Moffitt Cancer Center, Tampa, FL, USA
  • Frank Vrionis, Boca Raton Regional Hospital
  • Miroslaw Zabek, Mazovian Brodnowski Hospital, Warsaw, Mazowieckie, Poland
  • Martin Bexon, Medicenna Biopharma, Houston, TX, USA
Link
Disciplines
Publication Date
November 11, 2019
DOI
10.1093/NEUONC/NOZ175.029
Citation Information
John Sampson, Achal Singh Achrol, Manish Aghi, Krystof Bankiewicz, et al.. "ATIM-30. COMBATING RECURRENT GLIOBLASTOMA WITH MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, THROUGH MRI-GUIDED CONVECTIVE DELIVERY" Neuro-oncology Vol. 21 (2019)
Available at: http://works.bepress.com/achalsingh-achrol/66/